August 20, 2017 7:20 PM ET

Pharmaceuticals

Company Overview of Kala Pharmaceuticals, Inc.

Executive Profile

Mark T. Iwicki

Executive Chairman, CEO & President, Kala Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 9 Board Members in 9 different organizations across 10 different industries.

See Board Relationships
51$2,261,867
As of Fiscal Year 2016

Background

Mr. Mark T. Iwicki has been the Executive Chairman of Kala Pharmaceuticals, Inc. since April 2015 and its Chief Executive Officer and President since September 2015 and August 7, 2017 respectively. Mr. Iwicki served as the Chief Executive Officer and President of Civitas Therapeutics, Inc./Civitas Pharmaceuticals since January 29, 2014. He has more than 25 years of experience as a pharmaceutical industry leader managing all stages of drug development in multiple therapeutic ...

Corporate Headquarters

100 Beaver Street
Waltham, Massachusetts 02453

United States

Phone: 781-996-5252
Fax: 781-642-0399

Board Members Memberships

Director
Chairman of the Board
2014-Present
Director
2015-Present
Chairman
2015-Present
Director
2015-Present
Executive Chairman, CEO & President
2015-Present
Independent Director
2015-Present
Director
2016-Present
Director

Education

MBA
Loyola University Maryland
BSBA
Ball State University

Other Affiliations

Annual Compensation

Salary$472,738
Bonus$254,300
Total Annual Compensation$727,038

Stocks Options

All Other Compensation$1,298
Exercisable Options$522,440
Unexercisable Options$738,711
Total Number of Options$1,261,151

Total Compensation

Total Annual Cash Compensation$728,336
Total Short Term Compensation$727,038
Other Long Term Compensation$1,298
Total Calculated Compensation$2,261,867
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Kala Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.